Health Canada Approves Galderma’s Restylane SHAYPE for Chin Augmentation
Health Canada has given its nod to Restylane SHAYPE, a hyaluronic acid (HA) injectable designed for temporary augmentation of the chin region. Galderma Restylane SHAYPE will be available in Canada as of February 2024. Other regulatory reviews around the world are ongoing, the Company reports. Powered by new NASHA HD technology from Galderma, Restylane SHAYPE has the highest G’ (“G […]